Covered recipient · General Payments record
BRIAN D WEISS
Allopathic & Osteopathic Physicians Surgery Surgical Critical Care
General Payments · PY2024–2025
$9,221.18
- Reported across 18 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $6,500.00 | 1 |
| Travel and Lodging | $1,459.96 | 5 |
| Food and Beverage | $967.16 | 9 |
| Education | $199.94 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $8,794.76 | 11 |
| Astellas Pharma US Inc | $199.94 | 2 |
| Abbott Laboratories | $81.93 | 2 |
| ATRICURE, INC. | $25.90 | 1 |
| La Jolla Pharmaceutical Company | $24.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $50.32 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240856002 | CMS |
| Abbott Laboratories | $31.61 | 10/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240857697 | CMS |
| ABIOMED | $60.42 | 03/25/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1174872535 | CMS |
| ABIOMED | $108.75 | 03/25/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1174873836 | CMS |
| ABIOMED | $548.70 | 03/26/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1174874559 | CMS |
| ABIOMED | $306.60 | 03/26/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1174874638 | CMS |
| ABIOMED | $65.00 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174874662 | CMS |
| ABIOMED | $6,500.00 | 03/26/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1174874673 | CMS |
| ABIOMED | $26.82 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174872439 | CMS |
| ABIOMED | $13.10 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174873162 | CMS |
| ABIOMED | $60.25 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174873612 | CMS |
| ABIOMED | $669.63 | 04/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174872604 | CMS |
| ABIOMED | $435.49 | 04/04/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1174873555 | CMS |
| Astellas Pharma US Inc | $99.99 | 03/27/2025 | Education | Undisputed | 06/30/2026 | 1238608284 | CMS |
| Astellas Pharma US Inc | $99.95 | 03/27/2025 | Education | Undisputed | 06/30/2026 | 1238608286 | CMS |
| AtriCure, Inc. | $25.90 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223218475 | CMS |
| La Jolla Pharmaceutical Company | $24.53 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237497397 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.